A collaborative effort to open public access to antimalarial compounds has yielded discoveries not only in malaria research but also in efforts to combat trypanosomiasis and leishmaniasis. The project has also spawned a new initiative to open access to compounds known to be active against schistosomiasis, tuberculosis and various worm infections. "As understanding of and appreciation for open source research within the scientific community continues to grow, we are beginning to enter into an exciting time to be working in drug discovery for malaria and neglected diseases," writes Jeremy Burrows, chief of discovery at Medicines for Malaria Venture.

Related Summaries